Wells Fargo’s BioRestorative Therapies BRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-965
Closed -$1.96K 6496
2024
Q2
$1.96K Sell
965
-515
-35% -$1.05K ﹤0.01% 5636
2024
Q1
$2.04K Sell
1,480
-471
-24% -$650 ﹤0.01% 5640
2023
Q4
$3.4K Sell
1,951
-7,394
-79% -$12.9K ﹤0.01% 5572
2023
Q3
$16.7K Sell
9,345
-2,217
-19% -$3.97K ﹤0.01% 5295
2023
Q2
$51K Buy
11,562
+11,540
+52,455% +$50.9K ﹤0.01% 5140
2023
Q1
$75 Hold
22
﹤0.01% 6679
2022
Q4
$61 Buy
22
+1
+5% +$3 ﹤0.01% 6615
2022
Q3
$0 Buy
21
+3
+17% ﹤0.01% 6350
2022
Q2
$0 Buy
18
+2
+13% ﹤0.01% 6517
2022
Q1
$0 Buy
16
+2
+14% ﹤0.01% 6680
2021
Q4
$0 Buy
+14
New ﹤0.01% 6665